Atrial fibrillation (AF) is the most common cardiac arrhythmia in the United States and is
associated with increased morbidity, mortality, and health care expenditures. In this review …

Major bleeding (especially intracranial hemorrhage) is the most feared adverse event
observed in patients with atrial fibrillation (AF) receiving oral anticoagulation. Clinical risk …

Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging
because of enhanced risks for thrombosis and bleeding and the frequent need for invasive …

Aims To clarify the real-world clinical status and prognosis of elderly and very elderly non-
valvular atrial fibrillation (NVAF) patients, more than 30 000 elderly patients with NVAF …

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. The
asymptomatic nature and paroxysmal frequency of AF lead to suboptimal early detection. A …

Aims Patients with coronary and peripheral artery disease (PAD) have a residual risk of
major adverse cardiovascular and limb events despite standards of care. Among patients …

Background Atrial fibrillation is the most common recurrent arrhythmia in clinical practice,
with most clinical events occurring outside the hospital. Low detection and nonadherence to …

Purpose This study was designed to investigate the impact of single-nucleotide
polymorphism-encoded cytochrome P450 enzymes (CYP3A4/5) on clinical outcomes of …

A historical cohort analysis of the Japan medical data center (JMDC) claims databases was
performed to compare the incidence rates of bleeding events with warfarin (WF) versus …

Background and Purpose—Although patients with atrial fibrillation (AF) who experienced an
acute stroke are at high risk for recurrence, many patients are untreated or treated …